Paul Manning joins host Darcy Ungaro and Tanya aka ‘pumpkin’ to discuss how a business getting started in the shadows, is gearing up to shine…big time!

The emerging Potconomy is going to be huge! From an investment opportunity, there’s an increasing trend to invest in a way that’s in alignment with values and subject to your views on this product, investing in medical cannabis could soon be be factored into your portfolio. If you’re investing in a way aligned with a social good, and this could be one, you may soon find yourself in the company of a large crowd. When funding flows into an emerging market like this, especially one which is  then watch out, the potconomy is about to explode!

Helius therapeutics is a NZ company currently waiting for a licence to be approved to cultivate cannabis for research purposes. This $15m vertically integrated business is poised for great success, assuming the law changes of course! Paul Manning, one of the directors and co-founders of Helius Therapeutics, joined Darcy Ungaro on the ‘NZ Everyday Investor’ podcast recently to discuss how his business, and NZ could benefit tremendously, as this market matures.

The best advice Paul gave on the show to investors was to ‘look for sunrise industries, not sunset ones’.

Investing in tobacco, alcohol, oil, and weapons manufacturing could be considered sunset sectors. Cannabis will disrupt big pharma, potentially the same way that the electric vehicle movement is currently disrupting big oil. There are tremendous opportunities for Kiwi’s to enter this market – not just directly, but on the periphery too. Think of all the greenhouses, farms, and vineyards that now have another crop to diversify into.

The global legal cannabis industry could be worth conservatively $63.5b globally by 2024 in USD. NZ is a little bit behind if I’m honest, but I think we’re catching up!

Paul Manning is a New Zealand Young Entrepreneur of the Year and one of the country’s foremost leaders in the advertising and marketing sector.

Starting out as an entrepreneur at 22, Paul went on to build New Zealand’s largest independent communications agency. He later sold the company to global giant, Ogilvy & Mather. He has spent 15 years consulting to local and central government and advising major brands across every sector, including healthcare, pharmacy and agriculture.

Paul recently left his career running major communications agency, 99, to co-found the New Zealand-based bitotech startup, Helius Therapeutics – a company focused on the cultivation, research and manufacturing of medicinal cannabis products. Paul and the team have just raised $15m in series A capital, and are now leading this nascent industry in New Zealand.

Listen to the Podcast Here:


Show Links:

Where to find Paul:


Where to find Darcy Ungaro:

Ungaro &Co (registered) financial advisers




NZ Everyday Investor Podcast:

Subscribe to the podcast now to ensure you’re up to date!

We’re keeping it real on NZ Everyday investor – we’re not journalists and this isn’t an interview – it’s a discussion. If you like what we do, remember to subscribe to our show and share it with others – we’d really appreciate it! You know what else would be really spliffy? Write a review on facebook too!